busulfan has been researched along with Delayed Effects, Prenatal Exposure in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both busulfan treatment doses caused earlier occurrence of persistent estrus, with dose-dependence as compared to controls." | 5.33 | Reduction of primordial follicles caused by maternal treatment with busulfan promotes endometrial adenocarcinoma development in donryu rats. ( Maekawa, A; Shirota, M; Taya, K; Watanabe, G; Yoshida, M, 2005) |
| "Female Wistar rats were treated with busulfan or with solvent on Day 20 of pregnancy." | 3.67 | Effect of prenatal treatment with busulfan on the hypothalamo-pituitary axis, genital tract and testicular histology of prepubertal male rats. ( Barenton, B; Hochereau-de Reviers, MT; Perreau, C; Viguier-Martinez, MC, 1984) |
| "Busulfan is a bifunctional alkylating agent used for myeloablative conditioning and in the treatment of chronic myeloid leukemia due to its ability to cause DNA damage." | 1.56 | Maternal exposure to busulfan reduces the cell number in the somatosensory cortex associated with delayed somatic and reflex maturation in neonatal rats. ( Albuquerque, G; Costa-de-Santana, BJR; Gouveia, HJCB; Lacerda, DC; Manhães-de-Castro, R; Mendonça, CR; Toscano, AE; Visco, DB, 2020) |
| "Both busulfan treatment doses caused earlier occurrence of persistent estrus, with dose-dependence as compared to controls." | 1.33 | Reduction of primordial follicles caused by maternal treatment with busulfan promotes endometrial adenocarcinoma development in donryu rats. ( Maekawa, A; Shirota, M; Taya, K; Watanabe, G; Yoshida, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gouveia, HJCB | 1 |
| Manhães-de-Castro, R | 1 |
| Costa-de-Santana, BJR | 1 |
| Mendonça, CR | 1 |
| Albuquerque, G | 1 |
| Visco, DB | 1 |
| Lacerda, DC | 1 |
| Toscano, AE | 1 |
| Shirota, M | 2 |
| Soda, S | 1 |
| Katoh, C | 1 |
| Asai, S | 1 |
| Sato, M | 1 |
| Ohta, R | 1 |
| Watanabe, G | 2 |
| Taya, K | 2 |
| Shirota, K | 1 |
| Yoshida, M | 1 |
| Maekawa, A | 1 |
| Viguier-Martinez, MC | 1 |
| Hochereau-de Reviers, MT | 1 |
| Barenton, B | 1 |
| Perreau, C | 1 |
| Sanders, JE | 1 |
| Hawley, J | 1 |
| Levy, W | 1 |
| Gooley, T | 1 |
| Buckner, CD | 1 |
| Deeg, HJ | 1 |
| Doney, K | 1 |
| Storb, R | 1 |
| Sullivan, K | 1 |
| Witherspoon, R | 1 |
| Appelbaum, FR | 1 |
5 other studies available for busulfan and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
Maternal exposure to busulfan reduces the cell number in the somatosensory cortex associated with delayed somatic and reflex maturation in neonatal rats.
Topics: Alkylating Agents; Animals; Behavior, Animal; Body Weight; Busulfan; Cell Count; Female; Maternal Ex | 2020 |
Effects of reduction of the number of primordial follicles on follicular development to achieve puberty in female rats.
Topics: Alkylating Agents; Animals; Busulfan; Estradiol; Female; Follicle Stimulating Hormone; Inhibins; Lut | 2003 |
Reduction of primordial follicles caused by maternal treatment with busulfan promotes endometrial adenocarcinoma development in donryu rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Atrophy; Busulfan; Endometrial Neoplasms | 2005 |
Effect of prenatal treatment with busulfan on the hypothalamo-pituitary axis, genital tract and testicular histology of prepubertal male rats.
Topics: Animals; Busulfan; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hypothalamo | 1984 |
Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Female; Graft Rejection; Humans; Imm | 1996 |